Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
Brief Summary: To facilitate provision of atovaquone (566C80) to patients who have mild to moderate Pneumocystis carinii pneumonia (PCP) and are intolerant and/or unresponsive to trimethoprim / sulfamethoxazole (TMP / SMX ); to monitor serious adverse events attributable to 566C80.